Stay updated on Pembrolizumab in MPM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MPM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab in advanced malignant pleural mesothelioma is displayed, including study design, eligibility criteria, locations, outcome measures, and results-related information.
    Difference
    81%
    Check dated 2026-11-09T14:58:36.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the displayed page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:29:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about agencies adopting “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T16:46:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:52:01.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T04:44:58.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content. This indicates the record is temporarily unavailable or access is restricted, preventing viewing the trial details.
    Difference
    19%
    Check dated 2026-09-21T22:41:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.